These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 30521994

  • 1. A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease.
    Martini F, Rosa SG, Klann IP, Fulco BCW, Carvalho FB, Rahmeier FL, Fernandes MC, Nogueira CW.
    J Psychiatr Res; 2019 Feb; 109():107-117. PubMed ID: 30521994
    [Abstract] [Full Text] [Related]

  • 2. Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer's disease.
    Klann IP, Martini F, Rosa SG, Nogueira CW.
    Mol Biol Rep; 2020 Mar; 47(3):2205-2215. PubMed ID: 32095983
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats.
    Unsal C, Oran M, Albayrak Y, Aktas C, Erboga M, Topcu B, Uygur R, Tulubas F, Yanartas O, Ates O, Ozen OA.
    Toxicol Ind Health; 2016 Apr; 32(4):730-40. PubMed ID: 24231787
    [Abstract] [Full Text] [Related]

  • 4. Selenothymidine protects against biochemical and behavioral alterations induced by ICV-STZ model of dementia in mice.
    Thomé GR, Oliveira VA, Chitolina Schetinger MR, Saraiva RA, Souza D, Dorneles Rodrigues OE, Teixeira Rocha JB, Ineu RP, Pereira ME.
    Chem Biol Interact; 2018 Oct 01; 294():135-143. PubMed ID: 30120923
    [Abstract] [Full Text] [Related]

  • 5. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y, Tan Y, Zheng Y, Du X, Liu Q.
    J Biol Inorg Chem; 2017 Aug 01; 22(6):851-865. PubMed ID: 28502066
    [Abstract] [Full Text] [Related]

  • 6. Ellagic Acid Reverses Alterations in the Expression of AMPA Receptor and Its Scaffolding Proteins in the Cerebral Cortex and Memory Decline in STZ-sporadic Alzheimer' s Disease Mouse Model.
    Singh NAK, Prasad S.
    Psychopharmacology (Berl); 2024 Oct 01; 241(10):2117-2131. PubMed ID: 38842699
    [Abstract] [Full Text] [Related]

  • 7. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
    Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P, Islam F.
    Brain Res; 2009 Jul 24; 1281():117-27. PubMed ID: 19374888
    [Abstract] [Full Text] [Related]

  • 8. Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats.
    Moosavi M, Hooshmandi E, Javadpour P, Maghsoudi N, Katinger H, Ghasemi R.
    Behav Brain Res; 2020 Apr 20; 384():112554. PubMed ID: 32057828
    [Abstract] [Full Text] [Related]

  • 9. Anthocyanins as a potential pharmacological agent to manage memory deficit, oxidative stress and alterations in ion pump activity induced by experimental sporadic dementia of Alzheimer's type.
    Pacheco SM, Soares MSP, Gutierres JM, Gerzson MFB, Carvalho FB, Azambuja JH, Schetinger MRC, Stefanello FM, Spanevello RM.
    J Nutr Biochem; 2018 Jun 20; 56():193-204. PubMed ID: 29587242
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effects of berberine on recognition memory impairment, oxidative stress, and damage to the purinergic system in rats submitted to intracerebroventricular injection of streptozotocin.
    de Oliveira JS, Abdalla FH, Dornelles GL, Palma TV, Signor C, da Silva Bernardi J, Baldissarelli J, Lenz LS, de Oliveira VA, Chitolina Schetinger MR, Melchiors Morsch VM, Rubin MA, de Andrade CM.
    Psychopharmacology (Berl); 2019 Feb 20; 236(2):641-655. PubMed ID: 30377748
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer's disease.
    Kheradmand E, Hajizadeh Moghaddam A, Zare M.
    Biomed Pharmacother; 2018 Jan 20; 97():1096-1101. PubMed ID: 29136946
    [Abstract] [Full Text] [Related]

  • 12. Ebselen inhibits the activity of acetylcholinesterase globular isoform G4 in vitro and attenuates scopolamine-induced amnesia in mice.
    Martini F, Pesarico AP, Brüning CA, Zeni G, Nogueira CW.
    J Cell Biochem; 2018 Jul 20; 119(7):5598-5608. PubMed ID: 29405440
    [Abstract] [Full Text] [Related]

  • 13. Glucagon-like peptide-2 rescues memory impairments and neuropathological changes in a mouse model of dementia induced by the intracerebroventricular administration of streptozotocin.
    Sasaki-Hamada S, Ikeda M, Oka JI.
    Sci Rep; 2019 Sep 23; 9(1):13723. PubMed ID: 31548563
    [Abstract] [Full Text] [Related]

  • 14. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
    Liu C, Wu Y, Zha S, Liu M, Wang Y, Yang G, Ma K, Fei Y, Zhang Y, Hu X, Yang W, Qian Y.
    Brain Res; 2016 Jan 15; 1631():137-46. PubMed ID: 26656068
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotector effect of p,p'-methoxyl-diphenyl diselenide in a model of sporadic dementia of Alzheimer's type in mice: contribution of antioxidant mechanism.
    Pinton S, da Rocha JT, Gai BM, Prigol M, da Rosa LV, Nogueira CW.
    Cell Biochem Funct; 2011 Apr 15; 29(3):235-43. PubMed ID: 21465495
    [Abstract] [Full Text] [Related]

  • 16. S-Nitrosoglutathione Attenuates Oxidative Stress and Improves Retention Memory Dysfunctions in Intra-Cerebroventricular-Streptozotocin Rat Model of Sporadic Alzheimer's Disease via Activation of BDNF and Nuclear Factor Erythroid 2-Related Factor-2 Antioxidant Signaling Pathway.
    Dubey H, Ray A, Dubey A, Gulati K.
    Neuropsychobiology; 2024 Apr 15; 83(2):101-113. PubMed ID: 38744261
    [Abstract] [Full Text] [Related]

  • 17. Nanocurcumin prevents memory impairment, hippocampal apoptosis, Akt and CaMKII-α signaling disruption in the central STZ model of Alzheimer's disease in rat.
    Moosavi M, Soukhaklari R, Bagheri-Mohammadi S, Firouzan B, Javadpour P, Ghasemi R.
    Behav Brain Res; 2024 Aug 05; 471():115129. PubMed ID: 38942084
    [Abstract] [Full Text] [Related]

  • 18. Arbutin reduces cognitive deficit and oxidative stress in animal model of Alzheimer's disease.
    Dastan Z, Pouramir M, Ghasemi-Kasman M, Ghasemzadeh Z, Dadgar M, Gol M, Ashrafpour M, Pourghasem M, Moghadamnia AA, Khafri S.
    Int J Neurosci; 2019 Nov 05; 129(11):1145-1153. PubMed ID: 31251091
    [Abstract] [Full Text] [Related]

  • 19. Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model.
    Ponce-Lopez T, Liy-Salmeron G, Hong E, Meneses A.
    Brain Res; 2011 Dec 02; 1426():73-85. PubMed ID: 22036080
    [Abstract] [Full Text] [Related]

  • 20. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
    Salkovic-Petrisic M, Knezovic A, Osmanovic-Barilar J, Smailovic U, Trkulja V, Riederer P, Amit T, Mandel S, Youdim MB.
    Life Sci; 2015 Sep 01; 136():108-19. PubMed ID: 26159898
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.